Here's What Happens to a Company's Stock When the FDA Rejects Its Drug Application - Money Magazine

Money Magazine

Here's What Happens to a Company's Stock When the FDA Rejects Its Drug Application Money Magazine Adamis Pharmaceuticals said on Monday the U.S. Food and Drug Administration rejected its emergency treatment for acute anaphylaxis, a severe allergic reaction, for the second time. The San Diego-based drug developer's stock lost more than half its ... and more »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNEf5_-_hJ7o6OVgZR2QeOPtBSEUbg&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779128179472&ei=f4dVV8j_IdOZ3AGXgoa4DQ&url=http://time.com/money/4358160/adamis-pharmaceuticals-fda-rejection/
via IFTTT